U.S. markets open in 7 hours 3 minutes
  • S&P Futures

    4,148.75
    +2.00 (+0.05%)
     
  • Dow Futures

    32,773.00
    +16.00 (+0.05%)
     
  • Nasdaq Futures

    13,251.50
    +22.75 (+0.17%)
     
  • Russell 2000 Futures

    1,922.60
    +0.80 (+0.04%)
     
  • Crude Oil

    89.72
    +0.71 (+0.80%)
     
  • Gold

    1,772.60
    -0.30 (-0.02%)
     
  • Silver

    19.89
    +0.05 (+0.24%)
     
  • EUR/USD

    1.0188
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    2.8400
    0.0000 (0.00%)
     
  • Vix

    21.15
    -0.29 (-1.35%)
     
  • GBP/USD

    1.2079
    +0.0009 (+0.07%)
     
  • USD/JPY

    135.4230
    +0.4530 (+0.34%)
     
  • BTC-USD

    23,606.04
    +598.79 (+2.60%)
     
  • CMC Crypto 200

    549.33
    +14.10 (+2.63%)
     
  • FTSE 100

    7,439.74
    -8.32 (-0.11%)
     
  • Nikkei 225

    28,249.24
    +73.37 (+0.26%)
     

Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

HAWTHORNE, N.Y., July 26, 2022--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro") announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission (the "SEC"), is available within the Investor Relations section of Taro’s website at www.taro.com.

Hard copies of the report may be ordered free of charge by sending requests to:

Taro Pharmaceuticals U.S.A., Inc.
3 Skyline Drive
Hawthorne, NY 10532
Attn.: William J. Coote or
via email to William.Coote@taro.com

Additionally, the report may be accessed on the SEC’s website at www.sec.gov.

****

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220726006103/en/

Contacts

William J. Coote
VP, CFO
(914) 345-9001
William.Coote@taro.com